EnsoData, a Madison, WI-based AI health care company helping clinicians uncover disease while patients sleep, closed a $20 million Series A extension funding.
The round was led by Inspire Medical Systems, Inc. (NYSE: INSP), with participation from existing investors including Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 Ventures, Board members Justin Mortara, Fred Robertson, MD, and other investors.
With this new funding, the company will scale multinational expansion and commercial distribution partnerships, continue building out its team, and expand its product offerings to address new customer use cases and features to enable more accurate, affordable, and accessible care globally.
Company: EnsoData, Inc.
Round Series A
Funding Month: June 2022
Lead Investors: Inspire Medical Systems, Inc.
Additional Investors: Zetta Venture Partners, Venture Investors, Supermoon Capital, Colle Capital, HealthX Ventures, M25 Ventures, Board members Justin Mortara, Fred Robertson, MD, and other investors.
Company Website: https://www.ensodata.com/
Software Category: AI Health Care
About the Company: Led by Chris Fernandez, CEO, and Co-Founder, EnsoData is an AI healthcare technology company that performs complex and time-consuming data interpretation and analysis. EnsoData provides software-as-a-service (SaaS) that enables the discovery, identification, and actionable reporting of critical to understand patterns and trends in health data. EnsoData’s technology unlocks the vast wealth of clinical expertise lying dormant in archived data; by leveraging big data and analytics engine, EnsoData enables software to automatically perform complex and time, consuming data interpretation previously left to clinicians. Their first product, EnsoSleep, uses big data and advanced algorithms to automate the scoring of sleep studies.